Oestrogen-mediated cardioprotection following ischaemia and reperfusion is mimicked by an oestrogen receptor (ER)α agonist and unaffected by an ERβ antagonist
Open Access
- 31 March 2008
- journal article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 197 (3), 493-501
- https://doi.org/10.1677/JOE-08-0071
Abstract
Oestrogen protects the heart from ischaemic injury. The current study aims to characterise two novel oestrogen receptor (ER) ligands, an ERα agonist ERA-45 and an ERβ antagonist ERB-88, and then use them to investigate the roles of ERα and ERβ in mediating the cardioprotection by E from ischaemia–reperfusion injury in the rat. The ER ligands were characterised by gene transactivation assay using ER-transfected Chinese hamster ovary (CHO) cells and in bioavailability studies in vivo. Female rats (n=48) were ovariectomised and implanted with 17β-oestradiol (17βE2) releasing or placebo pellets. ERA-45, ERB-88 or vehicle was administered for 5 days prior to ischaemia–reperfusion studies. Necrosis, neutrophil infiltration (myeloperoxidase activity) and oxidant stress production (electron paramagnetic resonance) from the area-at-risk were measured to assess reperfusion injury. The ERα agonist ERA-45 showed more than 35-fold selectivity for ERα compared with ERβ gene transactivation. In vitro, the ERβ antagonist ERB-88 inhibited transactivation by 17βE2 via ERβ with 46-fold selectivity relative to inhibition via ERα. In vivo, 17βE2 significantly reduced neutrophil infiltration, oxidant stress and necrosis following ischaemia and reperfusion. Cardioprotection by 17βE2 was not inhibited by ERB-88 but was completely reproduced by ERA-45. In conclusion, protection of the rat heart after ischaemia–reperfusion by 17βE2 is achieved through the reduction of cardiomyocyte death, neutrophil infiltration and oxygen-free radical availability.The results of this study indicate that these effects are primarily mediated via activation of ERα.Keywords
This publication has 44 references indexed in Scilit:
- Activation of estrogen receptor-α protects the in vivo rabbit heart from ischemia-reperfusion injuryAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- 17β‐oestradiol up‐regulates longevity‐related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFκB cascadeAging Cell, 2005
- Estrogen receptor beta mediates gender differences in ischemia/reperfusion injuryJournal of Molecular and Cellular Cardiology, 2005
- 17β-Estradiol as a Receptor-Mediated Cardioprotective AgentJournal of Pharmacology and Experimental Therapeutics, 2003
- Response-Specific and Ligand Dose-Dependent Modulation of Estrogen Receptor (ER) α Activity by ERβ in the UterusEndocrinology, 2003
- Receptor profiling and endocrine interactions of tiboloneSteroids, 2002
- Oestrogen and the cardiovascular system: the good, the bad and the puzzlingTrends in Pharmacological Sciences, 2001
- Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism.Hypertension, 2001
- Cardiac myocytes and fibroblasts contain functional estrogen receptors1FEBS Letters, 1997
- Protection from Myocardial Reperfusion Injury by Acute Administration of 17β-EstradiolJournal of Molecular and Cellular Cardiology, 1996